Fmr LLC Intra Cellular Therapies, Inc. Transaction History

Fmr LLC

$1.6 Trillion
Q4 2024

A detailed history of Fmr LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Fmr LLC holds 11,076,445 shares of ITCI stock, worth $1.46 Billion. This represents 0.06% of its overall portfolio holdings.

Number of Shares

11,076,445

Previous 11,121,652 0.41%

Holding current value

$1.46 Billion

Previous $813 Million 13.76%

% of portfolio

0.06%

Previous 0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$71.19 - $91.57 $3.22 Million - $4.14 Million	-45,207 Reduced 0.41%	11,076,445 $925 Million
Q3 2024 Nov 13, 2024	SELL	$67.99 - $80.84 $7.9 Million - $9.39 Million	-116,146 Reduced 1.03%	11,121,652 $813 Million
Q2 2024 Aug 13, 2024	BUY	$64.76 - $79.84 $2.8 Million - $3.45 Million	43,185 Added 0.39%	11,237,798 $770 Million
Q1 2024 May 13, 2024	SELL	$64.37 - $75.65 $16.9 Million - $19.9 Million	-263,081 Reduced 2.3%	11,194,613 $775 Million
Q4 2023 Feb 13, 2024	BUY	$46.37 - $73.65 $22.2 Million - $35.2 Million	477,984 Added 4.35%	11,457,694 $821 Million
Q3 2023 Nov 13, 2023	SELL	$52.09 - $64.1 $10.6 Million - $13.1 Million	-203,786 Reduced 1.82%	10,979,710 $572 Million
Q2 2023 Aug 11, 2023	SELL	$54.67 - $66.44 $41.4 Million - $50.3 Million	-756,645 Reduced 6.34%	11,183,496 $708 Million
Q1 2023 May 11, 2023	SELL	$43.8 - $56.99 $3.88 Million - $5.05 Million	-88,649 Reduced 0.74%	11,940,141 $647 Million
Q4 2022 Feb 13, 2023	BUY	$44.07 - $54.45 $77.5 Million - $95.8 Million	1,758,793 Added 17.13%	12,028,790 $637 Million
Q3 2022 Nov 10, 2022	SELL	$42.7 - $59.99 $2.69 Million - $3.78 Million	-63,066 Reduced 0.61%	10,269,997 $478 Million
Q2 2022 Aug 12, 2022	SELL	$43.0 - $65.64 $26.7 Million - $40.8 Million	-621,647 Reduced 5.67%	10,333,063 $590 Million
Q1 2022 May 13, 2022	SELL	$38.74 - $62.09 $281,213 - $450,711	-7,259 Reduced 0.07%	10,954,710 $670 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $53.42 $4.19 Million - $6.36 Million	-119,027 Reduced 1.07%	10,961,969 $574 Million
Q3 2021 Nov 15, 2021	SELL	$28.72 - $42.49 $29.9 Million - $44.3 Million	-1,041,898 Reduced 8.59%	11,080,996 $413 Million
Q2 2021 Aug 13, 2021	BUY	$29.3 - $44.5 $355 Million - $539 Million	12,122,894 New	12,122,894 $495 Million

Others Institutions Holding ITCI

# of Institutions

416

Shares Held

87.6M

Call Options Held

284K

Put Options Held

105K

View Full List

About Intra-Cellular Therapies, Inc.

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $12.4B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

More about ITCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account